Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:antibiotic |
| gptkbp:activeIngredient |
gptkb:cephalexin
|
| gptkbp:approvedBy |
gptkb:FDA
1971 |
| gptkbp:ATCCode |
gptkb:J01DB01
|
| gptkbp:availableOn |
gptkb:tablet
capsule oral suspension |
| gptkbp:CASNumber |
15686-71-2
|
| gptkbp:chemicalFormula |
C16H17N3O4S
|
| gptkbp:contraindication |
allergy to cephalosporins
|
| gptkbp:drugClass |
cephalosporin
|
| gptkbp:eliminationHalfLife |
0.5 to 1.2 hours
|
| gptkbp:excretion |
renal
|
| https://www.w3.org/2000/01/rdf-schema#label |
Keflex
|
| gptkbp:indication |
skin infections
urinary tract infections respiratory tract infections bone infections |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea rash |
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:Upjohn_Company
|
| gptkbp:bfsLayer |
6
|